Shree Precoated (533110)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Reported ROE of 33.15% suggests some historical capital efficiency, though current zero revenue makes it unreliable.
• Price of ₹15.09 is below the 52-week high of ₹19.00, so there is no obvious speculative froth in the quote.
• Latest quarterly loss is negligible at ₹-0 crore, meaning near-term cash burn appears limited.
• Market cap of ₹6 crore leaves room for a meaningful recovery if operations restart profitably.

Concerns

• Latest quarter sales are ₹0 crore and net profit is ₹-0 crore, indicating no active operating revenue.
• Piotroski F-Score of 2/9 flags weak financial health and deteriorating fundamentals.
• P/E, book value, debt/equity, and promoter holding are unavailable, making valuation and governance assessment impossible.
• Profit growth is negative at -12.50% and dividend yield is 0%, so there is no earnings or income support.

AI Analysis

Friends, Graham taught me that investing is most intelligent when it is most businesslike. I cannot call any of this businesslike. Shree Precoated trades at ₹15.09 with a market cap of only ₹6 crore, but the latest quarter shows a silent engine: sales are ₹0 crore and net profit is ₹-0 crore. Profit growth is already negative at -12.5%. A reported ROE of 33.15% would normally catch my eye, but with zero revenue and a small loss, that number is not supported by current operations. ROCE of 0.00% confirms no profitable use of capital. The Piotroski F-Score of 2 out of 9 is a serious red flag; it suggests deteriorating profitability, leverage, and operating efficiency. I cannot compute a meaningful P/E, book value, debt-to-equity, or promoter holding—the data are simply absent. In Graham's world, an investor without information is a gambler, and the burden of proof lies with the company, not with me. At ₹6 crore market cap, any order or asset event can move the price, but that is speculation, not investing. There is no dividend, so I am not paid to wait. The 52-week range of ₹10.03 to ₹19.00 shows the stock is below its high, but cheapness without an earnings record or balance sheet is not value. I would need to see a credible path back to positive revenue and profit. Until then, this belongs on the too-hard pile. The wise investor does not need to act on every stock; he acts only when the odds are clearly in his favour.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer